Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Proc Natl Acad Sci U S A
1994 Aug 30;9118:8329-33.
Show Gene links
Show Anatomy links
Mos oncogene product associates with kinetochores in mammalian somatic cells and disrupts mitotic progression.
Wang XM
,
Yew N
,
Peloquin JG
,
Vande Woude GF
,
Borisy GG
.
???displayArticle.abstract???
The mos protooncogene has opposing effects on cell cycle progression. It is required for reinitiation of meiotic maturation and for meiotic progression through metaphase II, yet it is an active component of cytostatic factor. mos is a potent oncogene in fibroblasts, but high levels of expression are lethal. The lethality of mos gene expression in mammalian cells could be a consequence of a blockage induced by its cytostatic factor-related activity, which may appear at high dosage in mitotic cells. We have directly tested whether expression of the Mos protein can block mitosis in mammalian cells by microinjecting a fusion protein between Escherichia coli maltose-binding protein and Xenopus c-Mos into PtK1 epithelial cells and analyzing the cells by video time-lapse and immunofluorescence microscopy. Time-course analyses showed that Mos blocked mitosis by preventing progression to a normal metaphase. Chromosomes frequently failed to attain a bipolar orientation and were found near one pole. Injection of a kinase-deficient mutant Mos had no effect on mitosis, indicating that the blockage of mitotic progression required Mos kinase activity. Antitubulin immunostaining of cells blocked by Mos showed that microtubules were present but that spindle morphology was abnormal. Immunostaining for the Mos fusion protein showed that both wild-type and kinase mutant proteins localized at the kinetochores. Our results suggest that mitotic blockage by Mos may result from an action of the Mos kinase on the kinetochores, thus increasing chromosome instability and preventing normal congression.
Fischinger,
Quantitative interactions of feline leukaemia virus and its pseudotype of murine sarcoma virus in cat cells: requirement for DNA synthesis.
1971, Pubmed
Fischinger,
Quantitative interactions of feline leukaemia virus and its pseudotype of murine sarcoma virus in cat cells: requirement for DNA synthesis.
1971,
Pubmed
Freeman,
Xenopus homolog of the mos protooncogene transforms mammalian fibroblasts and induces maturation of Xenopus oocytes.
1989,
Pubmed
,
Xenbase
Gorbsky,
Microtubules of the kinetochore fiber turn over in metaphase but not in anaphase.
1989,
Pubmed
Gorbsky,
Differential expression of a phosphoepitope at the kinetochores of moving chromosomes.
1993,
Pubmed
Haccard,
Induction of metaphase arrest in cleaving Xenopus embryos by MAP kinase.
1993,
Pubmed
,
Xenbase
Hyman,
Two different microtubule-based motor activities with opposite polarities in kinetochores.
1991,
Pubmed
Masui,
Cytoplasmic control of nuclear behavior during meiotic maturation of frog oocytes.
1971,
Pubmed
Mitchison,
Sites of microtubule assembly and disassembly in the mitotic spindle.
1986,
Pubmed
Mitchison,
Polewards microtubule flux in the mitotic spindle: evidence from photoactivation of fluorescence.
1989,
Pubmed
Nicklas,
Mitosis.
1971,
Pubmed
Papkoff,
Detection of a transforming gene product in cells transformed by Moloney murine sarcoma virus.
1982,
Pubmed
Pfarr,
Cytoplasmic dynein is localized to kinetochores during mitosis.
1990,
Pubmed
Posada,
Mos stimulates MAP kinase in Xenopus oocytes and activates a MAP kinase kinase in vitro.
1993,
Pubmed
,
Xenbase
Rattner,
p34cdc2 kinase is localized to distinct domains within the mitotic apparatus.
1990,
Pubmed
Roy,
The cyclin B2 component of MPF is a substrate for the c-mos(xe) proto-oncogene product.
1990,
Pubmed
,
Xenbase
Sagata,
Function of c-mos proto-oncogene product in meiotic maturation in Xenopus oocytes.
1988,
Pubmed
,
Xenbase
Sagata,
The product of the mos proto-oncogene as a candidate "initiator" for oocyte maturation.
1989,
Pubmed
,
Xenbase
Salmon,
Spindle microtubule dynamics in sea urchin embryos: analysis using a fluorescein-labeled tubulin and measurements of fluorescence redistribution after laser photobleaching.
1984,
Pubmed
Sawin,
Evidence for kinesin-related proteins in the mitotic apparatus using peptide antibodies.
1992,
Pubmed
,
Xenbase
Simerly,
Microinjected centromere [corrected] kinetochore antibodies interfere with chromosome movement in meiotic and mitotic mouse oocytes.
1990,
Pubmed
Singh,
p37mos-associated serine/threonine protein kinase activity correlates with the cellular transformation function of v-mos.
1986,
Pubmed
Steuer,
Localization of cytoplasmic dynein to mitotic spindles and kinetochores.
1990,
Pubmed
Vandenbunder,
Decoration of microtubules by fluorescently labeled microtubule-associated protein 2 (MAP2) does not interfere with their spatial organization and progress through mitosis in living fibroblasts.
1986,
Pubmed
Vandré,
Anaphase onset and dephosphorylation of mitotic phosphoproteins occur concomitantly.
1989,
Pubmed
Verlhac,
MAP kinase becomes stably activated at metaphase and is associated with microtubule-organizing centers during meiotic maturation of mouse oocytes.
1993,
Pubmed
Watanabe,
Specific proteolysis of the c-mos proto-oncogene product by calpain on fertilization of Xenopus eggs.
1989,
Pubmed
,
Xenbase
Yen,
CENP-E is a putative kinetochore motor that accumulates just before mitosis.
1992,
Pubmed
Yew,
mos gene transforming efficiencies correlate with oocyte maturation and cytostatic factor activities.
1991,
Pubmed
,
Xenbase
Yew,
Meiotic initiation by the mos protein in Xenopus.
1992,
Pubmed
,
Xenbase
Yew,
Mos and the cell cycle: the molecular basis of the transformed phenotype.
1993,
Pubmed
Zhou,
Ability of the c-mos product to associate with and phosphorylate tubulin.
1991,
Pubmed
,
Xenbase
Zhou,
pp39mos is associated with p34cdc2 kinase in c-mosxe-transformed NIH 3T3 cells.
1992,
Pubmed
